Annual Retained Earnings
$10.31 B
+$269.70 M+2.69%
31 December 2023
Summary:
Eli Lilly and Company annual retained earnings is currently $10.31 billion, with the most recent change of +$269.70 million (+2.69%) on 31 December 2023. During the last 3 years, it has risen by +$2.48 billion (+31.70%). LLY annual retained earnings is now -39.31% below its all-time high of $16.99 billion, reached on 31 December 2013.LLY Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
$13.63 B
+$449.20 M+3.41%
30 September 2024
Summary:
Eli Lilly and Company quarterly retained earnings is currently $13.63 billion, with the most recent change of +$449.20 million (+3.41%) on 30 September 2024. Over the past year, it has increased by +$3.32 billion (+32.18%). LLY quarterly retained earnings is now -23.49% below its all-time high of $17.81 billion, reached on 30 September 2013.LLY Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LLY Retained Earnings Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +2.7% | +32.2% |
3 y3 years | +31.7% | +41.4% |
5 y5 years | -9.5% | +173.5% |
LLY Retained Earnings High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +31.7% | at high | +59.3% |
5 y | 5 years | -9.5% | +109.6% | at high | +176.9% |
alltime | all time | -39.3% | +313.0% | -23.5% | +445.7% |
Eli Lilly And Company Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $13.63 B(+3.4%) |
June 2024 | - | $13.18 B(+5.0%) |
Mar 2024 | - | $12.55 B(+21.7%) |
Dec 2023 | $10.31 B(+2.7%) | $10.31 B(+0.0%) |
Sept 2023 | - | $10.31 B(-0.6%) |
June 2023 | - | $10.37 B(-2.5%) |
Mar 2023 | - | $10.64 B(+5.9%) |
Dec 2022 | $10.04 B(+12.1%) | $10.04 B(+0.4%) |
Sept 2022 | - | $10.01 B(+17.0%) |
June 2022 | - | $8.56 B(-8.7%) |
Mar 2022 | - | $9.37 B(+4.6%) |
Dec 2021 | $8.96 B(+14.4%) | $8.96 B(-7.1%) |
Sept 2021 | - | $9.64 B(+13.0%) |
June 2021 | - | $8.53 B(-7.1%) |
Mar 2021 | - | $9.18 B(+17.3%) |
Dec 2020 | $7.83 B(+59.1%) | $7.83 B(+9.5%) |
Sept 2020 | - | $7.15 B(+8.1%) |
June 2020 | - | $6.62 B(+12.5%) |
Mar 2020 | - | $5.88 B(+19.5%) |
Dec 2019 | $4.92 B(-56.8%) | $4.92 B(-1.2%) |
Sept 2019 | - | $4.98 B(+15.4%) |
June 2019 | - | $4.32 B(-11.5%) |
Mar 2019 | - | $4.88 B(-57.2%) |
Dec 2018 | $11.40 B(-18.0%) | $11.40 B(-20.9%) |
Sept 2018 | - | $14.41 B(+1.1%) |
June 2018 | - | $14.25 B(-14.2%) |
Mar 2018 | - | $16.61 B(+19.5%) |
Dec 2017 | $13.89 B(-13.4%) | $13.89 B(-13.9%) |
Sept 2017 | - | $16.15 B(+3.6%) |
June 2017 | - | $15.59 B(-1.8%) |
Mar 2017 | - | $15.88 B(-1.1%) |
Dec 2016 | $16.05 B(+0.2%) | $16.05 B(-3.3%) |
Sept 2016 | - | $16.60 B(+4.9%) |
June 2016 | - | $15.82 B(-2.0%) |
Mar 2016 | - | $16.16 B(+0.9%) |
Dec 2015 | $16.01 B(-2.9%) | $16.01 B(-5.0%) |
Sept 2015 | - | $16.86 B(+4.6%) |
June 2015 | - | $16.11 B(-3.5%) |
Mar 2015 | - | $16.71 B(+1.4%) |
Dec 2014 | $16.48 B(-3.0%) | $16.48 B(-5.3%) |
Sept 2014 | - | $17.41 B(+1.2%) |
June 2014 | - | $17.20 B(-2.6%) |
Mar 2014 | - | $17.67 B(+4.0%) |
Dec 2013 | $16.99 B(+5.6%) | $16.99 B(-4.6%) |
Sept 2013 | - | $17.81 B(+7.2%) |
June 2013 | - | $16.61 B(+0.9%) |
Mar 2013 | - | $16.46 B(+2.3%) |
Dec 2012 | $16.09 B(+8.0%) | $16.09 B(-5.7%) |
Sept 2012 | - | $17.06 B(+8.4%) |
June 2012 | - | $15.74 B(-1.1%) |
Mar 2012 | - | $15.91 B(+6.8%) |
Dec 2011 | $14.90 B(+17.0%) | $14.90 B(-1.5%) |
Sept 2011 | - | $15.13 B(+8.9%) |
June 2011 | - | $13.89 B(+0.7%) |
Mar 2011 | - | $13.79 B(+8.3%) |
Dec 2010 | $12.73 B(+29.5%) | $12.73 B(+12.2%) |
June 2010 | - | $11.34 B(+2.4%) |
Mar 2010 | - | $11.08 B(+12.7%) |
Dec 2009 | $9.83 B(+28.4%) | $9.83 B(-1.6%) |
Sept 2009 | - | $9.99 B(+10.4%) |
June 2009 | - | $9.05 B(+0.9%) |
Mar 2009 | - | $8.97 B(+17.2%) |
Dec 2008 | $7.65 B(-35.2%) | $7.65 B(-37.9%) |
Sept 2008 | - | $12.34 B(-3.6%) |
June 2008 | - | $12.80 B(-1.8%) |
Mar 2008 | - | $13.03 B(+10.4%) |
Dec 2007 | $11.81 B(+8.1%) | $11.81 B(-2.3%) |
Sept 2007 | - | $12.09 B(+8.3%) |
June 2007 | - | $11.16 B(-2.3%) |
Mar 2007 | - | $11.43 B(+4.6%) |
Dec 2006 | $10.93 B | $10.93 B(-6.5%) |
Sept 2006 | - | $11.69 B(+8.1%) |
June 2006 | - | $10.82 B(-0.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2006 | - | $10.87 B(+8.4%) |
Dec 2005 | $10.03 B(+3.1%) | $10.03 B(-1.4%) |
Sept 2005 | - | $10.17 B(+8.4%) |
June 2005 | - | $9.38 B(-10.3%) |
Mar 2005 | - | $10.46 B(+7.6%) |
Dec 2004 | $9.72 B(+2.7%) | $9.72 B(-7.6%) |
Sept 2004 | - | $10.53 B(+7.9%) |
June 2004 | - | $9.76 B(-1.3%) |
Mar 2004 | - | $9.88 B(+4.4%) |
Dec 2003 | $9.47 B(+11.4%) | $9.47 B(+0.3%) |
Sept 2003 | - | $9.44 B(+8.8%) |
June 2003 | - | $8.68 B(-2.4%) |
Mar 2003 | - | $8.89 B(+4.5%) |
Dec 2002 | $8.50 B(+14.7%) | $8.50 B(-1.3%) |
Sept 2002 | - | $8.61 B(+8.5%) |
June 2002 | - | $7.94 B(-1.5%) |
Mar 2002 | - | $8.05 B(+8.7%) |
Dec 2001 | $7.41 B(+19.1%) | $7.41 B(-2.3%) |
Sept 2001 | - | $7.59 B(+7.5%) |
June 2001 | - | $7.06 B(+2.8%) |
Mar 2001 | - | $6.87 B(+10.3%) |
Dec 2000 | $6.22 B(+24.8%) | $6.22 B(-0.6%) |
Sept 2000 | - | $6.26 B(+11.2%) |
June 2000 | - | $5.63 B(-1.5%) |
Mar 2000 | - | $5.72 B(+14.7%) |
Dec 1999 | $4.99 B(+17.9%) | $4.99 B(+3.8%) |
Sept 1999 | - | $4.80 B(+8.6%) |
June 1999 | - | $4.43 B(-7.7%) |
Mar 1999 | - | $4.80 B(+13.4%) |
Dec 1998 | $4.23 B(-5.7%) | $4.23 B(-2.2%) |
Sept 1998 | - | $4.33 B(-4.4%) |
June 1998 | - | $4.52 B(-0.6%) |
Mar 1998 | - | $4.55 B(+1.5%) |
Dec 1997 | $4.48 B(-37.8%) | $4.48 B(-15.5%) |
Sept 1997 | - | $5.30 B(-5.9%) |
June 1997 | - | $5.63 B(-26.2%) |
Mar 1997 | - | $7.63 B(+5.9%) |
Dec 1996 | $7.21 B(+11.2%) | $7.21 B(-0.3%) |
Sept 1996 | - | $7.23 B(+3.1%) |
June 1996 | - | $7.01 B(+1.9%) |
Mar 1996 | - | $6.88 B(+6.1%) |
Dec 1995 | $6.48 B(+28.1%) | $6.48 B(-2.8%) |
Sept 1995 | - | $6.67 B(+18.8%) |
June 1995 | - | $5.61 B(+2.7%) |
Mar 1995 | - | $5.47 B(+8.0%) |
Dec 1994 | $5.06 B(+12.5%) | $5.06 B(-1.6%) |
Sept 1994 | - | $5.14 B(+2.9%) |
June 1994 | - | $5.00 B(+3.4%) |
Mar 1994 | - | $4.83 B(+7.4%) |
Dec 1993 | $4.50 B(-5.1%) | $4.50 B(-16.4%) |
Sept 1993 | - | $5.38 B(+2.2%) |
June 1993 | - | $5.27 B(+3.3%) |
Mar 1993 | - | $5.10 B(+7.5%) |
Dec 1992 | $4.74 B(+1.1%) | $4.74 B(-0.5%) |
Sept 1992 | - | $4.77 B(-10.2%) |
June 1992 | - | $5.31 B(+3.5%) |
Mar 1992 | - | $5.14 B(+9.4%) |
Dec 1991 | $4.69 B(+3.2%) | $4.69 B(+0.1%) |
Sept 1991 | - | $4.69 B(+3.3%) |
June 1991 | - | $4.54 B(+3.9%) |
Mar 1991 | - | $4.37 B(-4.0%) |
Dec 1990 | $4.55 B(+11.9%) | $4.55 B(-0.6%) |
Sept 1990 | - | $4.57 B(+2.8%) |
June 1990 | - | $4.45 B(+1.4%) |
Mar 1990 | - | $4.39 B(+7.9%) |
Dec 1989 | $4.07 B(+6.2%) | $4.07 B(-0.9%) |
Sept 1989 | - | $4.10 B(+1.4%) |
June 1989 | - | $4.04 B(+5.6%) |
Dec 1988 | $3.83 B(+12.7%) | $3.83 B(+12.7%) |
Dec 1987 | $3.40 B(+11.7%) | $3.40 B(+11.7%) |
Dec 1986 | $3.04 B(+11.0%) | $3.04 B(+11.0%) |
Dec 1985 | $2.74 B(+9.8%) | $2.74 B(+9.8%) |
Dec 1984 | $2.50 B | $2.50 B |
FAQ
- What is Eli Lilly and Company annual retained earnings?
- What is the all time high annual retained earnings for Eli Lilly and Company?
- What is Eli Lilly and Company annual retained earnings year-on-year change?
- What is Eli Lilly and Company quarterly retained earnings?
- What is the all time high quarterly retained earnings for Eli Lilly and Company?
- What is Eli Lilly and Company quarterly retained earnings year-on-year change?
What is Eli Lilly and Company annual retained earnings?
The current annual retained earnings of LLY is $10.31 B
What is the all time high annual retained earnings for Eli Lilly and Company?
Eli Lilly and Company all-time high annual retained earnings is $16.99 B
What is Eli Lilly and Company annual retained earnings year-on-year change?
Over the past year, LLY annual retained earnings has changed by +$269.70 M (+2.69%)
What is Eli Lilly and Company quarterly retained earnings?
The current quarterly retained earnings of LLY is $13.63 B
What is the all time high quarterly retained earnings for Eli Lilly and Company?
Eli Lilly and Company all-time high quarterly retained earnings is $17.81 B
What is Eli Lilly and Company quarterly retained earnings year-on-year change?
Over the past year, LLY quarterly retained earnings has changed by +$3.32 B (+32.18%)